Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
18.48
-0.09 (-0.48%)
At close: Oct 30, 2026, 4:00 PM EDT
19.89
+1.41 (7.63%)
After-hours: Oct 30, 2026, 7:56 PM EDT
Nuvectis Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Selling, General & Admin | 2.51 | 2.15 | 2.53 | 2.02 | 2.98 | 1.89 | 1.95 | 1.54 | 1.7 | 1.74 | 2.6 | 1.67 | 1.51 | 1.73 | 2.38 | 1.42 | 1.07 | 1.14 | 1.12 | 0.51 |
Research & Development | 4.68 | 4.11 | 5.09 | 5.77 | 3.61 | 3.68 | 4.5 | 2.82 | 2.94 | 2.66 | 3.27 | 4.49 | 4.26 | 2.37 | 3.2 | 4.52 | 2.51 | 1.81 | -5.96 | 4.16 |
Operating Expenses | 7.2 | 6.26 | 7.62 | 7.79 | 6.6 | 5.57 | 6.45 | 4.36 | 4.64 | 4.4 | 5.87 | 6.16 | 5.77 | 4.1 | 5.58 | 5.94 | 3.57 | 2.95 | -4.84 | 4.67 |
Operating Income | -7.2 | -6.26 | -7.62 | -7.79 | -6.6 | -5.57 | -6.45 | -4.36 | -4.64 | -4.4 | -5.87 | -6.16 | -5.77 | -4.1 | -5.58 | -5.94 | -3.57 | -2.95 | 4.84 | -4.67 |
Interest & Investment Income | 0.18 | 0.21 | 0.3 | 0.33 | 0.26 | 0.24 | 0.2 | 0.21 | 0.22 | 0.23 | 0.24 | 0.28 | 0.06 | 0.05 | 0.08 | 0.06 | 0 | 0 | 0 | - |
EBT Excluding Unusual Items | -7.02 | -6.05 | -7.31 | -7.46 | -6.33 | -5.33 | -6.25 | -4.15 | -4.43 | -4.17 | -5.62 | -5.88 | -5.71 | -4.05 | -5.5 | -5.88 | -3.57 | -2.94 | 4.84 | -4.67 |
Other Unusual Items | - | - | - | - | - | - | - | - | - | - | -1 | - | - | - | -1.2 | - | - | - | -7.1 | - |
Pretax Income | -7.02 | -6.05 | -7.31 | -7.46 | -6.33 | -5.33 | -6.25 | -4.15 | -4.43 | -4.17 | -6.62 | -5.88 | -5.71 | -4.05 | -6.7 | -5.88 | -3.57 | -2.94 | -2.26 | -4.67 |
Net Income | -7.02 | -6.05 | -7.31 | -7.46 | -6.33 | -5.33 | -6.25 | -4.15 | -4.43 | -4.17 | -6.62 | -5.88 | -5.71 | -4.05 | -6.7 | -5.88 | -3.57 | -2.94 | -2.26 | -4.67 |
Preferred Dividends & Other Adjustments | - | - | - | 2.43 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -7.02 | -6.05 | -7.31 | -9.89 | -6.33 | -5.33 | -6.25 | -4.15 | -4.43 | -4.17 | -6.62 | -5.88 | -5.71 | -4.05 | -6.7 | -5.88 | -3.57 | -2.94 | -2.26 | -4.67 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 23 | 23 | 23 | 23 | 21 | 20 | 18 | 17 | 17 | 17 | 16 | 16 | 15 | 15 | 15 | 14 | 13 | 9 | 5 | 5 |
Shares Outstanding (Diluted) | 23 | 23 | 23 | 23 | 21 | 20 | 18 | 17 | 17 | 17 | 16 | 16 | 15 | 15 | 15 | 14 | 13 | 9 | 5 | 5 |
Shares Change (YoY) | 9.87% | 17.44% | 30.63% | 31.85% | 26.42% | 20.40% | 9.61% | 6.99% | 11.35% | 12.46% | 10.48% | 14.62% | 19.35% | 60.76% | 225.29% | 211.85% | 206.04% | 134.85% | - | - |
EPS (Basic) | -0.30 | -0.26 | -0.32 | -0.44 | -0.30 | -0.27 | -0.35 | -0.24 | -0.26 | -0.25 | -0.41 | -0.37 | -0.38 | -0.27 | -0.46 | -0.42 | -0.28 | -0.32 | -0.50 | -1.04 |
EPS (Diluted) | -0.30 | -0.26 | -0.32 | -0.44 | -0.30 | -0.27 | -0.35 | -0.24 | -0.26 | -0.25 | -0.41 | -0.37 | -0.38 | -0.27 | -0.46 | -0.42 | -0.28 | -0.32 | -0.50 | -1.04 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
EBIT | -7.2 | -6.26 | -7.62 | -7.79 | -6.6 | -5.57 | -6.45 | -4.36 | -4.64 | -4.4 | -5.87 | -6.16 | -5.77 | -4.1 | -5.58 | -5.94 | -3.57 | -2.95 | 4.84 | -4.67 |